Miller Anestesia

224. Celerier E, Rivat C, Jun Y, et al: Long-lasting hype-

ralgesia induced by fentanyl in rats: Preventive effect

of ketamine. Anesthesiology 92:465–472, 2000.

225. Mao J, Price DD, Mayer DJ: Mechanisms of hype-

ralgesia and morphine tolerance: A current view of

their possible interactions. Pain 62:259–274, 1995.

226. Li X, Angst MS, Clark JD: Opioid-induced hyperal-

gesia and incisional pain.Anesth Analg 93:204–209,

2001.

227. Li X, Clark JD: Hyperalgesia during opioid absti-

nence: Mediation by glutamate and substance p.

Anesth Analg 95:979–984, 2002.

228. Kissin I, Bright CA, Bradley EL Jr: Acute tolerance

to continuously infused alfentanil: The role of cho-

lecystokinin and

-methyl-d-aspartate–nitric oxide

systems. Anesth Analg 91:110–116, 2000.

229. Li JY, Wong CH, Huang EY, et al: Modulations of

spinal serotonin activity affect the development of

morphine tolerance. Anesth Analg 92:1563–1568,

2001.

230. Laulin JP, Maurette P, Corcuff JB, et al: The role of

ketamine in preventing fentanyl-induced hyperal-

gesia and subsequent acute morphine tolerance.

Anesth Analg 94:1263–1269, 2002.

231. Kissin I, Bright CA, Bradley EL Jr: The effect of

ketamine on opioid-induced acute tolerance: Can it

explain reduction of opioid consumption with

ketamine-opioid analgesic combinations? Anesth

Analg 91:1483–1488, 2000.

232. Holtman JR Jr, Wala EP: Characterization of the

antinociceptive and pronociceptive effects of metha-

done in rats. Anesthesiology 106:563–571, 2007.

233. Dunbar SA, Karamian I, Roberts L, Zhang J: Increa-

sed prostaglandin E

release and activated Akt/beta-

catenin signaling pathway occur after opioid

withdrawal in rat spinal cord. Anesthesiology 105:

154–159, 2006.

234. Troster A, Sittl R, Singler B, et al: Modulation of

remifentanil-induced analgesia and postinfusion

hyperalgesia by parecoxib in humans. Anesthesio-

logy 105:1016–1023, 2006.

235. Liang DY, Liao G, Wang J, et al: A genetic analysis

of opioid-induced hyperalgesia in mice.Anesthesio-

logy 104:1054–1062, 2006.

236. Angst MS, Clark JD: Opioid-induced hyperalgesia:

A qualitative systematic review. Anesthesiology

104:570–587, 2006.

237. Stein C, Pfluger M,Yassouridis A, et al: No tolerance

to peripheral morphine analgesia in presence of

opioid expression in inflamed synovia. J Clin Invest

98:793–799, 1996.

238. Duttaroy A, Yoburn BC: The effect of intrinsic effi-

cacy on opioid tolerance. Anesthesiology 82:1226–

1236, 1995.

239. Ouellet DM, Pollack GM: Pharmacodynamics and

tolerance development during multiple intravenous

bolus morphine administration in rats. J Pharmacol

Exp Ther 281:713–720, 1997.

240. Hanks GW, Forbes K: Opioid responsiveness. Acta

Anaesthesiol Scand 41:154–158, 1997.

241. Mitra S, Sinatra RS: Perioperative management of

acute pain in the opioid-dependent patient. Anes-

thesiology 101:212–227, 2004.

242. Kienbaum P, Thurauf N, Michel MC, et al: Pro-

found increase in epinephrine concentration in

plasma and cardiovascular stimulation after

-opioid receptor blockade in opioid-addicted

patients during barbiturate-induced anesthesia for

acute detoxification. Anesthesiology 88:1154–1161,

1998.

243. Hensel M, Wolter S, Kox WJ: EEG controlled rapid

opioid withdrawal under general anaesthesia. Br J

Anaesth 84:236–238, 2000.

244. Kienbaum P, Heuter T, Michel MC, et al: Sympathe-

tic neural activation evoked by

-receptor blockade

in patients addicted to opioids is abolished by intra-

venous clonidine. Anesthesiology 96:346–351,

2002.

245. Salas SP, Roblero JS, Lopez LF, et al: [

-methyl-

Tyr1,

-methyl-Arg7-d-Leu8]-dynorphin-A-(1-8)

ethylamide, a stable dynorphin analog, produces

diuresis by kappa-opiate receptor activation in the

rat. J Pharmacol Exp Ther 262:979–986, 1992.

246. Pesonen A, Leppaluoto J, Ruskoaho H: Mechanism

of opioid-induced atrial natriuretic peptide release

in conscious rats. J Pharmacol Exp Ther 254:690–

695, 1990.

247. Kuipers PW, Kamphuis ET, van Venrooij GE, et al:

Intrathecal opioids and lower urinary tract function:

urodynamic

evaluation.

Anesthesiology

100:1497–1503, 2004.

248. Malinovsky JM, Le Normand L, Lepage JY, et al: The

urodynamic effects of intravenous opioids and keto-

profen in humans. Anesth Analg 87:456–461,

1998.

249. Rosow CE, Gomery P, Chen TY, et al: Reversal of

opioid-induced bladder dysfunction by intravenous

naloxone and methylnaltrexone. Clin Pharmacol

Ther 82:48–53, 2007.

250. Murphy DB, Sutton JA, Prescott LF, Murphy MB:

Opioid-induced delay in gastric emptying: A peri-

pheral mechanism in humans. Anesthesiology

87:765–770, 1997.

251. Kojima Y, Takahashi T, Fujina M, Owyang C: Inhi-

bition of cholinergic transmission by opiates in ileal

myenteric plexus is mediated by kappa receptor.

Involvement of regulatory inhibitory G protein and

calcium N-channels. J Pharmacol Exp Ther

268:965–970, 1994.

252. Penagini R, Picone A, Bianchi PA: Effect of mor-

phine and naloxone on motor response of the

human esophagus to swallowing and distension.

Am J Physiol 271:G675–680, 1996.

253. Thorn SE, Wattwil M, Lindberg G, Sawe J: Systemic

and central effects of morphine on gastroduodenal

motility. Acta Anaesthesiol Scand 40:177–186,

1996.

254. Crighton IM, Martin PH, Hobbs GJ, et al: A com-

parison of the effects of intravenous tramadol,

codeine, and morphine on gastric emptying in

human volunteers. Anesth Analg 87:445–449,

1998.

255. Yukioka H, Tanaka M, Fujimori M: Recovery of

bowel motility after high dose fentanyl or morphine

anaesthesia for cardiac surgery. Anaesthesia 45:353–

356, 1990.

256. Thorn SE, Wickbom G, Philipson L, et al: Myoelec-

tric activity in the stomach and duodenum after

epidural administration of morphine or bupiva-

caine. Acta Anaesthesiol Scand 40:773–778, 1996.

257. Runkel NS, Moody FG, Smith GS, et al: Alterations

in rat intestinal transit by morphine promote bacte-

rial translocation. Dig Dis Sci 38:1530–1536, 1993.

258. Hammas B, Thorn SE, Wattwil M: Propofol and

gastric effects of morphine. Acta Anaesthesiol

Scand 45:1023–1027, 2001.

259. Asai T, Power I: Naloxone inhibits gastric emptying

in the rat. Anesth Analg 88:204–208, 1999.

260. McNeill MJ, Ho ET, Kenny GN: Effect of IV meto-

clopramide on gastric emptying after opioid preme-

dication. Br J Anaesth 64:450–452, 1990.

261. Matot I, Eimerl D, Rabinovich Y, Udassin R: Effect

of morphine on small bowel propulsion after intes-

tinal ischemia. Anesthesiology 100:450–452, 2004.

262. Thompson DR: Narcotic analgesic effects on the

sphincter of Oddi: A review of the data and thera-

peutic implications in treating pancreatitis. Am J

Gastroenterol 96:1266–1272, 2001.

263. Wu SD, Zhang ZH, Jin JZ, et al: Effects of narcotic

analgesic drugs on human Oddi’s sphincter motility.

World J Gastroenterol 10:2901–2904, 2004.

264. Fragen RJ, Vilich F, Spies SM, Erwin WD: The effect

of remifentanil on biliary tract drainage into the

duodenum. Anesth Analg 89:1561–1564, 1999.

265. Fisher DM: The “big little problem” of postoperative

nausea and vomiting: Do we know the answer yet?

Anesthesiology 87:1271–1273, 1997.

266. Tramer MR, Reynolds DJ, Moore RA, McQuay HJ:

Efficacy,dose-response,and safety of ondansetron in

prevention of postoperative nausea and vomiting: A

quantitative systematic review of randomized place-

bo-controlled trials. Anesthesiology 87:1277–1289,

1997.

267. Watcha MF, White PF: Postoperative nausea and

vomiting. Its etiology, treatment, and prevention.

Anesthesiology 77:162–184, 1992.

268. Langevin S, Lessard MR, Trepanier CA, Baribault

JP: Alfentanil causes less postoperative nausea and

vomiting than equipotent doses of fentanyl or

sufentanil in outpatients. Anesthesiology 91:1666–

1673, 1999.

269. Raftery S, Sherry E: Total intravenous anaesthesia

with propofol and alfentanil protects against postope-

rative nausea and vomiting. Can J Anaesth 39:37–40,

1992.

270. Rung GW, Claybon L, Hord A, et al: Intravenous

ondansetron for postsurgical opioid-induced nausea

and vomiting. S3A-255 Study Group. Anesth Analg

84:832–838, 1997.

271. Tzeng JI, Wang JJ, Ho ST, et al: Dexamethasone for

prophylaxis of nausea and vomiting after epidural

morphine for post-caesarean section analgesia:

Comparison of droperidol and saline. Br J Anaesth

85:865–868, 2000.

272. Simoneau II, Hamza MS, Mata HP, et al: The can-

nabinoid agonist WIN55,212-2 suppresses opioid-

induced emesis in ferrets. Anesthesiology

94:882–887, 2001.

273. Stener-Victorin E, Waldenstrom U, Nilsson L, et al:

A prospective randomized study of electro-acu-

puncture versus alfentanil as anaesthesia during

oocyte aspiration in in-vitro fertilization. Hum

Reprod 14:2480–2484, 1999.

274. Lok IH, Chan MT, Chan DL, et al: A prospective

randomized trial comparing patient-controlled

sedation using propofol and alfentanil and physi-

cian-administered sedation using diazepam and

pethidine during transvaginal ultrasound–guided

oocyte retrieval. Hum Reprod 17:2101–2106, 2002.

275. Sandner-Kiesling A, Eisenach JC: Pharmacology of

opioid inhibition to noxious uterine cervical disten-

sion. Anesthesiology 97:966–971, 2002.

276. Sandner-Kiesling A, Eisenach JC: Estrogen reduces

efficacy of

- but not

-opioid agonist inhibition in

response to uterine cervical distension. Anesthesio-

logy 96:375–379, 2002.

277. Gin T, Ngan Kee WD, Siu YK, et al: Alfentanil given

immediately before the induction of anesthesia for

elective cesarean delivery. Anesth Analg 90:1167–

1172, 2000.

278. Vertommen JD, Marcus MA, Van Aken H: The

effects of intravenous and epidural sufentanil in the

chronic maternal-fetal sheep preparation. Anesth

Analg 80:71–75, 1995.

279. Strumper D, Durieux ME, Gogarten W, et al: Fetal

plasma concentrations after intraamniotic sufenta-

nil in chronically instrumented pregnant sheep.

Anesthesiology 98:1400–1406, discussion 1405A-

1406A, 2003.

Opioides

585

Sección

Farmacología y anestesia